Literature DB >> 6102426

Cerebrospinal fluid concentrations and serum protein binding of lorazepam and its conjugate.

L Aaltonen, J Kanto, M Salo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6102426     DOI： 10.1111/j.1600-0773.1980.tb02436.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  10 in total

Review 1.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

3.  Objective and subjective assessments of the effects of flupentixol and benzodiazepines on human psychomotor performance.

Authors:  M J Mattila; M Mattila; K Aranko
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Entry of lorazepam into cerebrospinal fluid.

Authors:  H R Ochs; J Busse; D J Greenblatt; M D Allen
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 5.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

6.  CSF penetration and pharmacokinetics of midazolam.

Authors:  S Sjövall; J Kanto; J J Himberg; M Hovi-Viander; M Salo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 8.  Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

9.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.